TY - JOUR
T1 - Peptide amphiphile nanofiber hydrogel delivery of Sonic hedgehog protein to the penis and cavernous nerve suppresses intrinsic and extrinsic apoptotic signaling mechanisms, which are an underlying cause of erectile dysfunction
AU - Martin, Sarah
AU - Harrington, Daniel A.
AU - Ohlander, Samuel
AU - Stupp, Samuel I.
AU - McVary, Kevin T.
AU - Podlasek, Carol A.
N1 - Funding Information:
This work was supported by the NIH / NIDDK DK101536 .
Funding Information:
This work was supported by the NIH/NIDDK DK101536.
Publisher Copyright:
© 2021
PY - 2021/10
Y1 - 2021/10
N2 - Erectile dysfunction (ED) is a common and debilitating condition with high impact on quality of life. An underlying cause of ED is apoptosis of penile smooth muscle, which occurs with cavernous nerve injury, in prostatectomy, diabetic and aging patients. We are developing peptide amphiphile (PA) nanofiber hydrogels as an in vivo delivery vehicle for Sonic hedgehog protein to the penis and cavernous nerve to prevent the apoptotic response. We examine two important aspects required for clinical application of the biomaterials: if SHH PA suppresses intrinsic (caspase 9) and extrinsic (caspase 8) apoptotic mechanisms, and if suppressing one apoptotic mechanism forces apoptosis to occur via a different mechanism. We show that SHH PA suppresses both caspase 9 and 8 apoptotic mechanisms, and suppressing caspase 9 did not shift signaling to caspase 8. SHH PA has significant clinical potential as a preventative ED therapy, by management of intrinsic and extrinsic apoptotic mechanisms.
AB - Erectile dysfunction (ED) is a common and debilitating condition with high impact on quality of life. An underlying cause of ED is apoptosis of penile smooth muscle, which occurs with cavernous nerve injury, in prostatectomy, diabetic and aging patients. We are developing peptide amphiphile (PA) nanofiber hydrogels as an in vivo delivery vehicle for Sonic hedgehog protein to the penis and cavernous nerve to prevent the apoptotic response. We examine two important aspects required for clinical application of the biomaterials: if SHH PA suppresses intrinsic (caspase 9) and extrinsic (caspase 8) apoptotic mechanisms, and if suppressing one apoptotic mechanism forces apoptosis to occur via a different mechanism. We show that SHH PA suppresses both caspase 9 and 8 apoptotic mechanisms, and suppressing caspase 9 did not shift signaling to caspase 8. SHH PA has significant clinical potential as a preventative ED therapy, by management of intrinsic and extrinsic apoptotic mechanisms.
KW - Cavernous nerve injury
KW - Erectile dysfunction
KW - Intrinsic and extrinsic apoptosis
KW - Penis
KW - Peptide amphiphile
KW - Peripheral nerve regeneration
KW - Sonic hedgehog
UR - http://www.scopus.com/inward/record.url?scp=85113411415&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85113411415&partnerID=8YFLogxK
U2 - 10.1016/j.nano.2021.102444
DO - 10.1016/j.nano.2021.102444
M3 - Article
C2 - 34314869
AN - SCOPUS:85113411415
VL - 37
JO - Nanomedicine: Nanotechnology, Biology, and Medicine
JF - Nanomedicine: Nanotechnology, Biology, and Medicine
SN - 1549-9634
M1 - 102444
ER -